Sofia A. Omari
Sydney, NSW 2052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia.
Journal: Science translational medicine
Published: May 17, 2023
In vitro and in vivo modelling of mutant JAK3/STAT5 signaling in leukemia.
Journal: Heliyon
Published: October 03, 2022
Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies.
Journal: Medical oncology (Northwood, London, England)
Published: August 08, 2021
HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort.
Journal: Oncogene
Published: June 21, 2021
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.
Journal: Nature communications
Published: April 08, 2020
A Point Mutation in IKAROS ZF1 Causes a B Cell Deficiency in Mice.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 10, 2019
TRPV1 Channels in Immune Cells and Hematological Malignancies.
Journal: Advances in pharmacology (San Diego, Calif.)
Published: May 23, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026